Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06059027 · ClinicalTrials.gov registry record
Microbes and Respiratory Illnesses
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 290
- Enrollment target
NCT06059027 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 290 participants.
The verdict
NCT06059027 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
Study Summary
This study is called the Microbes and Respiratory Illnesses (MARI) Study. Children growing up on farms are exposed to many types of microbes that could be beneficial. It is thought that increased exposure to certain types of microbes early in life helps to develop a healthy immune system and reduce the risk for severe common cold illnesses, breathing problems, and allergies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2023-10-18 |
| Est. Completion | 2025-11-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06059027
The ClinicalTrials.gov registry entry for NCT06059027 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06059027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06059027 about?
NCT06059027 is a clinical study titled "Microbes and Respiratory Illnesses". This study is called the Microbes and Respiratory Illnesses (MARI) Study. Children growing up on farms are exposed to many types of microbes that could be beneficial. It is thought that increased exposure to certain types of microbes early in life helps to develop a healthy immune system and reduce ...
What is the current status of trial NCT06059027?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2023-10-18. Estimated completion is 2025-11-06.
Who is sponsoring clinical trial NCT06059027?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.